These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

694 related articles for article (PubMed ID: 32636479)

  • 1. Pre-existing immunity to SARS-CoV-2: the knowns and unknowns.
    Sette A; Crotty S
    Nat Rev Immunol; 2020 Aug; 20(8):457-458. PubMed ID: 32636479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What the immune response to the coronavirus says about the prospects for a vaccine.
    Ledford H
    Nature; 2020 Sep; 585(7823):20-21. PubMed ID: 32811981
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronavirus reinfections: three questions scientists are asking.
    Ledford H
    Nature; 2020 Sep; 585(7824):168-169. PubMed ID: 32887957
    [No Abstract]   [Full Text] [Related]  

  • 4. Cellular immune responses to covid-19.
    Sewell HF; Agius RM; Stewart M; Kendrick D
    BMJ; 2020 Jul; 370():m3018. PubMed ID: 32737031
    [No Abstract]   [Full Text] [Related]  

  • 5. T cells found in coronavirus patients 'bode well' for long-term immunity.
    Leslie M
    Science; 2020 May; 368(6493):809-810. PubMed ID: 32439770
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19 and the Path to Immunity.
    Stephens DS; McElrath MJ
    JAMA; 2020 Oct; 324(13):1279-1281. PubMed ID: 32915201
    [No Abstract]   [Full Text] [Related]  

  • 7. Seeking and destroying the evils from the inside-translating cancer immunity to fight COVID-19.
    Dong H
    Cancer Immunol Immunother; 2020 Jun; 69(6):911-912. PubMed ID: 32347359
    [No Abstract]   [Full Text] [Related]  

  • 8. SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection.
    Altmann DM; Boyton RJ
    Sci Immunol; 2020 Jul; 5(49):. PubMed ID: 32680954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 herd immunity: where are we?
    Fontanet A; Cauchemez S
    Nat Rev Immunol; 2020 Oct; 20(10):583-584. PubMed ID: 32908300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The non-specific and sex-differential effects of vaccines.
    Aaby P; Benn CS; Flanagan KL; Klein SL; Kollmann TR; Lynn DJ; Shann F
    Nat Rev Immunol; 2020 Aug; 20(8):464-470. PubMed ID: 32461674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?
    Gursel M; Gursel I
    Allergy; 2020 Jul; 75(7):1815-1819. PubMed ID: 32339299
    [No Abstract]   [Full Text] [Related]  

  • 12. Dysregulated adaptive immune response contributes to severe COVID-19.
    Yu K; He J; Wu Y; Xie B; Liu X; Wei B; Zhou H; Lin B; Zuo Z; Wen W; Xu W; Zou B; Wei L; Huang X; Zhou P
    Cell Res; 2020 Sep; 30(9):814-816. PubMed ID: 32759967
    [No Abstract]   [Full Text] [Related]  

  • 13. Epitope similarity cannot explain the pre-formed T cell immunity towards structural SARS-CoV-2 proteins.
    Stervbo U; Rahmann S; Roch T; Westhoff TH; Babel N
    Sci Rep; 2020 Nov; 10(1):18995. PubMed ID: 33149224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm.
    Mahmoudi S; Rezaei M; Mansouri N; Marjani M; Mansouri D
    J Clin Immunol; 2020 Oct; 40(7):974-976. PubMed ID: 32648027
    [No Abstract]   [Full Text] [Related]  

  • 15. SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in 'lasso' for the multi-faced virus.
    Oberemok VV; Laikova KV; Yurchenko KA; Marochkin NA; Fomochkina II; Kubyshkin AV
    Inflamm Res; 2020 Sep; 69(9):801-812. PubMed ID: 32656668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines.
    Moise L; Ross TM; Hoft DF; Martin WD; De Groot AS
    Expert Rev Vaccines; 2020 Sep; 19(9):781-784. PubMed ID: 32962468
    [No Abstract]   [Full Text] [Related]  

  • 17. Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and "New Old Friends".
    Kleen TO; Galdon AA; MacDonald AS; Dalgleish AG
    Front Immunol; 2020; 11():2059. PubMed ID: 33013871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ethics of COVID-19 Immunity-Based Licenses ("Immunity Passports").
    Persad G; Emanuel EJ
    JAMA; 2020 Jun; 323(22):2241-2242. PubMed ID: 32374357
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimizing safety surveillance for COVID-19 vaccines.
    Chandler RE
    Nat Rev Immunol; 2020 Aug; 20(8):451-452. PubMed ID: 32555401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.
    Le Bert N; Tan AT; Kunasegaran K; Tham CYL; Hafezi M; Chia A; Chng MHY; Lin M; Tan N; Linster M; Chia WN; Chen MI; Wang LF; Ooi EE; Kalimuddin S; Tambyah PA; Low JG; Tan YJ; Bertoletti A
    Nature; 2020 Aug; 584(7821):457-462. PubMed ID: 32668444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.